Immunochemical Methods in the Clinical Laboratory Roger L. Bertholf, Ph.D., DABCC Mark A. Bowman, Ph.D., MT(ASCP)
The University of Florida
University of Florida Health Science Centers in Gainesville and Jacksonville
The University of Iowa
University of Iowa College of Medicine
Florida vs. Iowa
The American Society of Clinical Pathologists Marie Bass, MT(ASCP) Manager, ASCP Workshops for Laboratory Professionals Kathleen Dramisino, MT(ASCP) Workshop coordinator Tommie Ware A/V and materials support
Classification of immunochemical methods Particle methods Precipitation Immunodiffusion Immunoelectrophoresis Light scattering Nephelometry Turbidimetry Label methods Non-competitive One-site Two-site Competitive Heterogeneous Homogeneous
Properties of the antibody-antigen bond Non-covalent Reversible Intermolecular forces Coulombic interactions (hydrogen bonds) Hydrophobic interactions van der Waals (London) forces Clonal variation
Antibody affinity
Precipitation of antibody/antigen complexes Detection of the antibody/antigen complex depends on precipitation No label is involved Many precipitation methods are qualitative, but there are quantitative applications, too
Factors affecting solubility Size Charge Temperature Solvent ionic strength
The precipitin reaction etc. Precipitate Zone of equivalence Antibody/Antigen
Single radial immunodiffusion Ag
Single radial immunodiffusion
Electroimmunodiffusion Why would we want to combine immunodiffusion with electrophoresis? SPEED Specificity Carl-Bertil Laurell (Lund University, Sweden) Laurell Technique (coagulation factors) “Rocket electrophoresis”
Electroimmunodiffusion + -
Immunoelectrophoresis Combines serum protein electrophoresis with immunometric detection Electrophoresis provides separation Immunoprecipitation provides detection Two related applications: Immunoelectrophoresis Immunofixation electrophoresis
Immunoelectrophoresis + - -human serum Specimen
Immunoelectrophoresis + - P C P C P C
Immunofixation electrophoresis Immunochemical Methods (handout addendum) Immunofixation electrophoresis SPE IgG IgA IgM Bertholf and Bowman
Particle methods involving soluble complexes The key physical property is still size Measurement is based on how the large antibody/antigen complexes interact with light The fundamental principle upon which the measurement is made is light scattering Two analytical methods are based on light scattering: Nephelometry and Turbidimetry
Light reflection
Molecular size and scattering - +
Distribution of scattered radiation
Nephelometry vs. Turbidimetry 0°-90°
Rate nephelometry Intensity of scattering Time Rate C1 C2
Additional considerations for quantitative competitive binding immunoassays Response curve Hook effect
Competitive immunoassay response curve %Bound vs. log concentration %Bound label Antigen concentration
Log antigen concentration Logistic equation a %Bound label c Slope = b d Log antigen concentration
Log antigen concentration Logit transformation a %Bound label d Log antigen concentration
Log antigen concentration Logit plot Logit y Log antigen concentration
High dose “hook” effect %Bound antigen Antigen concentration
Analytical methods using labeled antigens/antibodies What is the function of the label? To provide a means by which the free antigens, or antigen/antibody complexes can be detected The label does not necessarily distinguish between free and bound antigens
Analytical methods using labeled antigens/antibodies What are desirable properties of labels? Easily attached to antigen/antibody Easily measured, with high S/N Does not interfere with antibody/antigen reaction Inexpensive/economical/non-toxic
Radioisotope labels Advantages Disadvantages Flexibility Sensitivity Size Disadvantages Toxicity Shelf life Disposal costs
Enzyme labels Advantages Disadvantages Diversity Amplification Versatility Disadvantages Lability Size Heterogeneity
Fluorescent labels Advantages Disadvantages Size Specificity Sensitivity Disadvantages Hardware Limited selection Background
Chemiluminescent labels Advantages Size Sensitivity S/N Disadvantages Hardware ?
Chemiluminescent labels
Chemiluminescent labels
Introduction to Heterogeneous Immunoassay What is the distinguishing feature of heterogeneous immunoassays? They require separation of bound and free ligands Do heterogeneous methods have any advantage(s) over homogeneous methods? Yes What are they? Sensitivity Specificity
Heterogeneous immunoassays Competitive Antigen excess Usually involves labeled competing antigen RIA is the prototype Non-competitive Antibody excess Usually involves secondary labeled antibody ELISA is the prototype
Enzyme-linked immunosorbent assay Substrate 2nd antibody E Specimen S P Microtiter well E
ELISA (variation 1) Specimen Labeled antigen E Microtiter well S P E
ELISA (variation 2) Labeled antibody E Specimen E Microtiter well
Human anti-animal antibodies Humans exposed to animals can produce antibodies to animal immunoglobulins Heterophilic antibodies Anti-isotypic Anti-idiotypic Human anti-mouse antibodies (HAMA) are most common Anti-animal antibodies can cross-link capture and detection reagent antibodies
Automated heterogeneous immunoassays The ELISA can be automated The separation step is key in the design of automated heterogeneous immunoassays Approaches to automated separation immobilized antibodies capture/filtration magnetic separation
Immobilized antibody methods Coated tube Coated bead Solid phase antibody methods
Coated tube methods Specimen Labeled antigen Wash
Coated bead methods
Microparticle enzyme immunoassay (MEIA) Labeled antibody E S P E Glass fiber matrix
Magnetic separation methods Fe
Magnetic separation methods Aspirate/Wash Fe
Electrochemiluminescence immunoassay (Elecsys™ system) Flow cell Oxidized Reduced Fe
ASCEND (Biosite Triage™)
ASCEND Wash
ASCEND Developer
Solid phase light scattering immunoassay
Introduction to Homogeneous Immunoassay What is the distinguishing feature of homogeneous immunoassays? They do not require separation of bound and free ligands Do homogeneous methods have any advantage(s) over heterogeneous methods? Yes What are they? Speed Adaptability
Homogeneous immunoassays Virtually all homogeneous immunoassays are one-site Virtually all homogeneous immunoassays are competitive Virtually all homogeneous immunoassays are designed for small antigens Therapeutic/abused drugs Steroid/peptide hormones
Typical design of a homogeneous immunoassay No signal Signal
Enzyme-multiplied immunoassay technique (EMIT™) Developed by Syva Corporation (Palo Alto, CA) in 1970s--now owned by Behring Diagnostics Offered an alternative to RIA or HPLC for measuring therapeutic drugs Sparked the widespread use of TDM Adaptable to virtually any chemistry analyzer Has both quantitative (TDM) and qualitative (DAU) applications; forensic drug testing is the most common use of the EMIT methods
EMIT™ method S Enzyme No signal S P Enzyme S Signal
EMIT™ signal/concentration curve Functional concentration range Signal (enzyme activity) Antigen concentration
Fluorescence polarization immunoassay (FPIA) Developed by Abbott Diagnostics, about the same time as the EMIT was developed by Syva Roche marketed FPIA methods for the Cobas FARA analyzer, but not have a significant impact on the market Like the EMIT, the first applications were for therapeutic drugs Currently the most widely used method for TDM Requires an Abbott instrument
Molecular electronic energy transitions Singlet A VR Triplet IC F P 10-6-10-9 sec 10-4-10 sec E0
Polarized radiation z y x Polarizing filter
Fluorescence polarization Fluorescein in out (10-6-10-9 sec) Orientation of polarized radiation is maintained!
Fluorescence polarization But. . . O H C Rotational frequency 1010 sec-1 in out (10-6-10-9 sec) Orientation of polarized radiation is NOT maintained!
Fluorescence polarization immunoassay Polarization maintained Slow rotation Rapid rotation Polarization lost
FPIA signal/concentration curve Functional concentration range Signal (I/I) Antigen concentration
Cloned enzyme donor immunoassay (CEDIA™) Developed by Microgenics in 1980s (purchased by BMC, then divested by Roche) Both TDM and DAU applications are available Adaptable to any chemistry analyzer Currently trails EMIT and FPIA applications in market penetration
Cloned enzyme donor Spontaneous Monomer (inactive) Active tetramer Acceptor Monomer (inactive)
Cloned enzyme donor immunoassay Acceptor No activity Acceptor Donor Active enzyme
CEDIA™ signal/concentration curve Immunochemical Methods (handout addendum) CEDIA™ signal/concentration curve Functional concentration range Signal (enzyme activity) Antigen concentration Bertholf and Bowman
Other approaches to homogeneous immunoassay Fluorescence methods Electrochemical methods Enzyme methods Enzyme channeling immunoassay
Substrate-labeled fluorescence immunoassay Enzyme No signal S Fluorescence Enzyme S Signal
Fluorescence excitation transfer immunoassay No signal Signal
Electrochemical differential polarographic immunoassay Oxidized Reduced
Prosthetic group immunoassay Enzyme No signal S P Enzyme P Signal
Enzyme channeling immunoassay Substrate Product 1 E1 Product 2 E2
Artificial antibodies Immunoglobulins have a limited shelf life Always require refrigeration Denaturation affects affinity, avidity Can we create more stable “artificial” antibodies? Molecular recognition molecules Molecular imprinting
Molecular imprinting
Immunochemical Methods (handout addendum) A final thought. . . “In science one tries to tell people, in such a way as to be understood by everyone, something that no one ever knew before. But in poetry, it's the exact opposite.” Paul Adrien Maurice Dirac (1902- 1984) Bertholf and Bowman